Taro-Zoledronic acid injection drug, used for osteoporosis and Page's disease, recalled because it may contain particulate matter
Critical priority
What you should do
- 1Check your product or contact your pharmacist to determine if it is affected.
- 2If you have a recalled product, do not use it and return it to your pharmacy for a replacement product and proper disposal.
- 3If you have used the recalled product and have health concerns, contact your healthcare provider.
- 4Go to the hospital immediately if you develop difficulty breathing, chest pain or confusion.
- 5Contact Taro Pharmaceuticals Inc. by calling toll free at 1-800-268-1975 if you have questions about this recall.
The issue
Product quality
Affected product
Taro-Zoledronic acid injection 5mg/100mL (DIN 02415100)
Where it was sold
Canada (national)Reported in the official notice — confirm there.
Issued by
Health Canada
Read the official Government of Canada notice
All recallsRecallGuardian ranks, illustrates and rewrites recalls in plain language. The official notice is authoritative — confirm model numbers, lot codes, dates and remedies there.